Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04109014 · ClinicalTrials.gov registry record · NA
FASTLANE II: Reducing Sex, Drug, and Mental Health Risk
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04109014 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 20 participants.
The verdict
NCT04109014, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The study uses a repeated measures, single group pretest-posttest design methodology to examine the feasibility, acceptability, and preliminary effectiveness of the FASTLANE II intervention aimed at decreasing risky sex behaviors among active methamphetamine using women. The study's methodology consists of two phases: 1) The feasibility and evaluation of recruitment capability and intervention effectiveness, and 2) qualitative acceptability interviews.
Interventions
- OTHER FASTLANE II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04109014
The ClinicalTrials.gov registry entry for NCT04109014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FASTLANE II is the first listed.
NCT04109014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04109014 about?
NCT04109014 is a clinical study titled "FASTLANE II: Reducing Sex, Drug, and Mental Health Risk". The study uses a repeated measures, single group pretest-posttest design methodology to examine the feasibility, acceptability, and preliminary effectiveness of the FASTLANE II intervention aimed at decreasing risky sex behaviors among active methamphetamine using women. The study's methodology cons...
What is the current status of trial NCT04109014?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-05-03. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04109014?
The interventions under investigation include: FASTLANE II (OTHER).
Who is sponsoring clinical trial NCT04109014?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.